Analyst Initiates Coverage on IDEAYA Biosciences with Buy Rating and 55 Price Target
BTIG analyst Justin Zelin has recently started covering IDEAYA Biosciences (NASDAQ: IDYA) and has given it a Buy rating with ...
© 2024 Stocks Today
Tag: IDYA
Popular News
-
Exploring the Rise of AI in Empowering Business and Personal Growth: Trends and Innovations
-
Unlocking the Future: The Rise of Open-Source FPGA Development Tools
-
The Future of Secure Communications: How Quantum-Resistant Encryption is Revolutionizing Wireless Technology
-
The Booming Market of Plant-Based Pharmaceuticals for Neurological Conditions
-
Unlocking Potential: How Recent Acquisitions in the Battery Technology Sector Are Reshaping the Energy Landscape